INTUITIVE SURGICAL INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.1B | $8.4B | $7.1B | $6.2B | $5.7B |
| Cost of revenue | $3.4B | $2.7B | $2.4B | $2.0B | $1.8B |
| Gross profit | $6.6B | $5.6B | $4.7B | $4.2B | $4.0B |
| Selling, general & administrative | $2.4B | $2.1B | $2.0B | $1.7B | $1.5B |
| Research and development | $1.3B | $1.1B | $998.8M | $879.0M | $671.0M |
| Operating expenses | $3.7B | $3.3B | $3.0B | $2.6B | $2.1B |
| Operating income | $2.9B | $2.3B | $1.8B | $1.6B | $1.8B |
| Pretax income | $3.3B | $2.7B | $2.0B | $1.6B | $1.9B |
| Income tax expense | $434.8M | $336.3M | $141.6M | $262.4M | $162.2M |
| Net income | $2.9B | $2.3B | $1.8B | $1.3B | $1.7B |
| Balance Sheet | |||||
| Cash and equivalents | $3.4B | $2.0B | $2.8B | $1.6B | $1.3B |
| Current assets | $9.8B | $7.1B | $7.9B | $6.3B | $5.8B |
| Total assets | $20.5B | $18.7B | $15.4B | $13.0B | $13.6B |
| Current liabilities | $2.0B | $1.7B | $1.7B | $1.4B | $1.1B |
| Total liabilities | $2.5B | $2.2B | $2.0B | $1.9B | $1.6B |
| Stockholders' equity | $17.8B | $16.4B | $13.3B | $11.0B | $11.9B |
| Cash Flow Statement | |||||
| Cash from operations | $3.0B | $2.4B | $1.8B | $1.5B | $2.1B |
| Depreciation and amortization | $600.0M | $439.0M | $382.0M | $326.0M | $280.0M |
| Stock-based compensation | $788.2M | $676.8M | $592.8M | $513.2M | $449.2M |
| Capital expenditure | $539.8M | $1.1B | $1.1B | $532.4M | $339.5M |
| Free cash flow | $2.5B | $1.3B | $749.6M | $958.4M | $1.7B |
| Share repurchases | $2.3B | $0 | $416.3M | $2.6B | $0 |
| Impairments | $0 | $0 | $0 | — | — |
Shares outstanding 354.2M · Free float 99.9%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.